These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9286624)

  • 61. Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats.
    Gillam M; Noto A; Zahradka P; Taylor CG
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):331-9. PubMed ID: 19864121
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
    Liu YL; Cawthorne MA; Stock MJ
    Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of selenium and vitamin E supplementation on lipid abnormalities in plasma, aorta, and adipose tissue of Zucker rats.
    Douillet C; Bost M; Accominotti M; Borson-Chazot F; Ciavatti M
    Biol Trace Elem Res; 1998 Dec; 65(3):221-36. PubMed ID: 9892495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic markers following beta-adrenoceptor agonist infusion in footshock-stressed rats.
    Verago JL; Grassi-Kassisse DM; Spadari-Bratfisch RC
    Braz J Med Biol Res; 2001 Sep; 34(9):1197-207. PubMed ID: 11514845
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A low dietary intake of cod protein is sufficient to increase growth, improve serum and tissue fatty acid compositions, and lower serum postprandial glucose and fasting non-esterified fatty acid concentrations in obese Zucker fa/fa rats.
    Drotningsvik A; Mjøs SA; Høgøy I; Remman T; Gudbrandsen OA
    Eur J Nutr; 2015 Oct; 54(7):1151-60. PubMed ID: 25380663
    [TBL] [Abstract][Full Text] [Related]  

  • 66. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
    Shibata T; Matsui K; Yonemori F; Wakitani K
    Br J Pharmacol; 1998 Dec; 125(8):1744-50. PubMed ID: 9886766
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimb.
    Eldershaw TP; Rattigan S; Cawthorne MA; Buckingham RE; Colquhoun EQ; Clark MG
    Horm Metab Res; 1995 Apr; 27(4):169-72. PubMed ID: 7750898
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
    Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Challenges in β(3)-Adrenoceptor Agonist Drug Development.
    Arch JR
    Ther Adv Endocrinol Metab; 2011 Apr; 2(2):59-64. PubMed ID: 23148171
    [No Abstract]   [Full Text] [Related]  

  • 71. Chronic treatment with BRL 35135 potentiates the action of insulin on lipid metabolism.
    Virtanen KA; Rouru J; Hänninen V; Savontaus E; Rouvari T; Teirmaa T; Koulu M; Huupponen R
    Eur J Pharmacol; 1997 Aug; 332(2):215-8. PubMed ID: 9286624
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2 -(3-chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents.
    Hashimoto K; Nagao Y; Ida K; Takeda M; Murakami N; Kato K; Mizota M
    Biochem Pharmacol; 1996 Nov; 52(10):1529-35. PubMed ID: 8937467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute injection of beta-adrenoceptor agonist BRL 35135 corrects both impaired uncoupling protein and lipoprotein lipase gene expression but not hypercapacity of lipogenesis in brown adipose tissue of suckling fa/fa rats.
    Marie V; Dupuy F; Bazin R
    Int J Obes Relat Metab Disord; 1994 May; 18(5):273-9. PubMed ID: 7914794
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
    Santti E; Huupponen R; Rouru J; Hänninen V; Pesonen U; Jhanwar-Uniyal M; Koulu M
    Br J Pharmacol; 1994 Dec; 113(4):1231-6. PubMed ID: 7889277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
    Liu YL; Sennitt MV; Hislop DC; Crombie DL; Heyman RA; Cawthorne MA
    Int J Obes Relat Metab Disord; 2000 Aug; 24(8):997-1004. PubMed ID: 10951538
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.